Nicorette Mint (Nicotine)

Nicotine, the active ingredient in Nicorette Mint, is a nicotine replacement therapy presented as a mint (oromucosal) for oromucosal use. It is intended to help adult smokers reduce cravings and manage withdrawal symptoms during smoking cessation. GNH USA supplies Nicorette Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicorette Mint is a nicotine replacement product that addresses tobacco dependence and supports quitting efforts. - Smoking cessation: helps adult smokers reduce cravings and withdrawal symptoms. - Tobacco dependence: provides controlled nicotine to replace cigarettes. - Relapse prevention: assists individuals who have quit to maintain abstinence.

Nicorette Mint may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Nausea: occasional upset stomach or feeling of queasiness. - Headache: mild to moderate headache during initial use. - Increased salivation: temporary excess saliva production.

Serious or Rare Side Effects: - Cardiovascular events: chest pain, palpitations, or hypertension in susceptible individuals. - Allergic reactions: rash, itching, swelling, or difficulty breathing requiring immediate medical attention.

When using Nicorette Mint, consider the following safety measures. - Cardiovascular assessment: evaluate patients with heart disease before initiating therapy. - Follow label instructions: do not exceed the recommended number of mints per day. - Non‑smoker use: avoid use in individuals who do not currently smoke. - Concomitant nicotine products: do not combine with other nicotine replacement therapies. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Nicotine may interact with several medicines, altering their effects.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may amplify nicotine’s cardiovascular effects. - Insulin: nicotine can affect blood glucose control, requiring dose adjustments.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors: may increase nicotine plasma levels. - Selective serotonin reuptake inhibitors (SSRIs): monitor for enhanced side effects. - Antihypertensive agents: nicotine may reduce blood pressure‑lowering efficacy.